Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2020 Feb 21;10:3548. doi: 10.1038/s41598-020-60644-9

Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial

Takeshi Morimoto 1,, Ichiro Sakuma 2, Mio Sakuma 1, Akihiro Tokushige 3, Masahiro Natsuaki 4, Tomohiro Asahi 5, Michio Shimabukuro 6, Takashi Nomiyama 7, Osamu Arasaki 8, Koichi Node 4, Shinichiro Ueda 3
PMCID: PMC7033276  PMID: 32080316

Correction to: Scientific Reports 10.1038/s41598-019-44885-x, published online 12 June 2019

This Article contains errors. The calculation method of LDL-C, presented in Figure 2 and 3 is described as being based on the Friedewald (F) equation. However, the data presented was calculated based on the direct method.

The correct Figures 2 and 3 appear below as Figures 1 and 2.

Figure 1.

Figure 1

Change in Low-density Lipoprotein-cholesterol calculated by F equation. LDL-C: low-density lipoprotein-cholesterol.

Figure 2.

Figure 2

Primary endpoint subgroup analyses calculated by F equation. LDL-C: Low density lipoprotein-cholesterol. BMI: body mass index. PCI: Percutaneous coronary intervention. CABG: Coronary artery bypass surgery. DPP-4: dipeptidylpeptidase-4. HbA1c: hemoglobin A1c.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES